Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial-Reference-Cited by-同舟云学术

Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial

Published:2018-01-31 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Mori Masaaki,Hara Takuma,Kikuchi Masako,Shimizu Hiroyuki,Miyamoto Tomoyuki,Iwashima Satoru^ORCID,Oonishi Tatsuya,Hashimoto Kunio,Kobayashi Norimoto,Waki Kenji,Suzuki Yasuo,Otsubo Yoshikazu,Yamada Hiroshi,Ishikawa Chikao,Kato Taichi,Fuse Shigeto

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-18387-7.pdf

Reference33 articles.

1. Uehara, R. & Belay, E. D. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 22, 79–85 (2012).

2. Saneeymehri, S., Baker, K. & So, T. Y. Overview of pharmacological treatment options for pediatric patients with refractory Kawasaki disease. J Pediatr Pharmacol Ther. 20, 163–177 (2015).

3. Patel, R. M. & Shulman, S. T. Kawasaki disease: a comprehensive review of treatment options. J Clin Pharm Ther. 40, 620–625 (2015).

4. A Scientific Statement for Health Professionals from the American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation. 135, e927–e999 (2017).

5. Moffett, B. S. et al. Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database. Pediatr Cardiol. 36, 374–378 (2015).

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Necrotic Change of Tunica Media Plays a Key Role in the Development of Coronary Artery Lesions in Kawasaki Disease;Circulation Journal;2024-08-06

2. Treatment intensification in Kawasaki disease – current perspectives;Expert Review of Clinical Immunology;2024-07-15

3. Research perspective in the clinical management of Kawasaki disease;Frontiers in Pediatrics;2024-07-09

4. TNF inhibitors in pediatric rheumatic diseases;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2024-06-20

5. Treatment of multisystem inflammatory syndrome in children;World Journal of Pediatrics;2024-03-21